Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Zak

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|April 17, 2018
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus DiseaseJerry F Brown, John M Dye, Sam Tozay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodHelder I Nakaya, Elizabeth Clutterbuck, Dmitri Kazmin, et al.
Mucosal Immunology|August 24, 2017
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
Mucosal Immunology|January 19, 2018
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
Mucosal Immunology|December 14, 2018
Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseasesReto Guler, Thabo Mpotje, Mumin Ozturk, et al.
Plos Computational Biology|March 29, 2008
Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamicsStephen A Ramsey, Sandy L Klemm, Daniel E Zak, et al.
Tuberculosis (Edinburgh, Scotland)|October 21, 2017
Host blood RNA signatures predict the outcome of tuberculosis treatmentEthan G Thompson, Ying Du, Stephanus T Malherbe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Systems analysis of protective immune responses to RTS,S malaria vaccination in humansDmitri Kazmin, Helder I Nakaya, Eva K Lee, et al.
AJPM Focus|October 27, 2023
Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described CohortKevin M Taylor, Keersten M Ricks, Paul A Kuehnert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responsesDaniel E Zak, Frank Schmitz, Elizabeth S Gold, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|April 17, 2018
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus DiseaseJerry F Brown, John M Dye, Sam Tozay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodHelder I Nakaya, Elizabeth Clutterbuck, Dmitri Kazmin, et al.
Mucosal Immunology|August 24, 2017
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
Mucosal Immunology|January 19, 2018
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
Mucosal Immunology|December 14, 2018
Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseasesReto Guler, Thabo Mpotje, Mumin Ozturk, et al.
Plos Computational Biology|March 29, 2008
Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamicsStephen A Ramsey, Sandy L Klemm, Daniel E Zak, et al.
Tuberculosis (Edinburgh, Scotland)|October 21, 2017
Host blood RNA signatures predict the outcome of tuberculosis treatmentEthan G Thompson, Ying Du, Stephanus T Malherbe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Systems analysis of protective immune responses to RTS,S malaria vaccination in humansDmitri Kazmin, Helder I Nakaya, Eva K Lee, et al.
AJPM Focus|October 27, 2023
Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described CohortKevin M Taylor, Keersten M Ricks, Paul A Kuehnert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responsesDaniel E Zak, Frank Schmitz, Elizabeth S Gold, et al.
Pageof 9